{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-124047","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2025-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.308042+00:00","generated_at":"2026-05-20T22:23:27.950939+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Biodesix shareholders approve reverse stock split ratio range 1:2 to 1:20","bullets":["Shareholders approved reverse stock split of common stock at ratio between 1-for-2 and 1-for-20, as determined by board.","KPMG LLP ratified as independent auditor for FY 2025 with 124.9M votes for.","ESPP amended: shares available increased by 1.45M; annual automatic increase cap raised to 3.0M.","Lawrence T. Kennedy Jr. and Matthew Strobeck elected as Class II directors at annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-124047","json":"https://secwatch.observer/filing/0001193125-25-124047.json","markdown":"https://secwatch.observer/filing/0001193125-25-124047.md","text":"https://secwatch.observer/filing/0001193125-25-124047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525124047/0001193125-25-124047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525124047/d19624d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T22:23:27.950939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}